EPRS1, glutamyl-prolyl-tRNA synthetase 1, 2058

N. diseases: 65; N. variants: 10
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4693733
Disease: LEUKODYSTROPHY, HYPOMYELINATING, 15
LEUKODYSTROPHY, HYPOMYELINATING, 15
0.400 GeneticVariation disease UNIPROT Bi-allelic Mutations in EPRS, Encoding the Glutamyl-Prolyl-Aminoacyl-tRNA Synthetase, Cause a Hypomyelinating Leukodystrophy. 29576217 2018
CUI: C4693733
Disease: LEUKODYSTROPHY, HYPOMYELINATING, 15
LEUKODYSTROPHY, HYPOMYELINATING, 15
0.400 CausalMutation disease CLINVAR
CUI: C2677112
Disease: Leukodystrophy, hypomyelinating
Leukodystrophy, hypomyelinating
0.300 Biomarker phenotype GENOMICS_ENGLAND Bi-allelic Mutations in EPRS, Encoding the Glutamyl-Prolyl-Aminoacyl-tRNA Synthetase, Cause a Hypomyelinating Leukodystrophy. 29576217 2018
CUI: C0015544
Disease: Failure to Thrive
Failure to Thrive
0.110 GeneticVariation disease BEFREE The clinical presentation of our patients differs from the original QARS-associated syndrome in the severe postnatal growth failure, absence of epilepsy, and minor MRI findings, thus further expanding the phenotypic spectrum of the glutaminyl-tRNA synthetase deficiency syndromes. 28620870 2017
CUI: C0557874
Disease: Global developmental delay
Global developmental delay
0.110 Biomarker disease BEFREE Glutaminyl-tRNA synthetase (QARS) deficiency has been described to be a cause of a neurodegenerative disorder associated with severe developmental delay, microcephaly, delayed myelination, and intractable epilepsy. 28056632 2017
CUI: C0015544
Disease: Failure to Thrive
Failure to Thrive
0.110 Biomarker disease HPO
CUI: C0557874
Disease: Global developmental delay
Global developmental delay
0.110 Biomarker disease HPO
CUI: C0206161
Disease: Reticulocyte count (procedure)
Reticulocyte count (procedure)
0.100 GeneticVariation phenotype GWASCAT The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. 27863252 2016
CUI: C0002418
Disease: Amblyopia
Amblyopia
0.100 Biomarker phenotype HPO
CUI: C0004134
Disease: Ataxia
Ataxia
0.100 Biomarker phenotype HPO
CUI: C0004158
Disease: Athetosis
Athetosis
0.100 Biomarker phenotype HPO
CUI: C0011168
Disease: Deglutition Disorders
Deglutition Disorders
0.100 Biomarker group HPO
CUI: C0013421
Disease: Dystonia
Dystonia
0.100 Biomarker phenotype HPO
CUI: C0020490
Disease: Hyperopia
Hyperopia
0.100 Biomarker disease HPO
CUI: C0023520
Disease: Leukodystrophy
Leukodystrophy
0.100 Biomarker disease HPO
CUI: C0026838
Disease: Muscle Spasticity
Muscle Spasticity
0.100 Biomarker phenotype HPO
CUI: C0028738
Disease: Nystagmus
Nystagmus
0.100 Biomarker disease HPO
CUI: C0029124
Disease: Optic Atrophy
Optic Atrophy
0.100 Biomarker disease HPO
CUI: C0232466
Disease: Feeding difficulties
Feeding difficulties
0.100 Biomarker phenotype HPO
CUI: C0234132
Disease: Pyramidal sign
Pyramidal sign
0.100 Biomarker phenotype HPO
CUI: C0234376
Disease: Action Tremor
Action Tremor
0.100 Biomarker phenotype HPO
CUI: C0235946
Disease: Cerebral atrophy
Cerebral atrophy
0.100 Biomarker disease HPO
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.100 Biomarker disease HPO
CUI: C0344482
Disease: Hypoplasia of corpus callosum
Hypoplasia of corpus callosum
0.100 Biomarker disease HPO
CUI: C1836830
Disease: Developmental regression
Developmental regression
0.100 Biomarker disease HPO